Archiwum hase³
fibrolytic | Plummer\'s disease | vascularized tissue | vascularized | pedicle flap | learning curve | auricular | lober pneumonia | supraventricular | prominent hilar vascularity | hilar | hilum | bolster | amenorrhoeic | intracranial hemorrhage | blood retina barrier | Conn's syndrome | wryneck | wry neck | lupus anticoagulant {LA} | paraesthesia | pneumocystosis | Riedel`s goitre | Stent Implantation System | herniology | Bassini’s operation | biogeochemistry | mandatory vaccination | amygdalase | Lauren classification | Reiter's arthritis | Endoscopic submucosal dissection technique {ESD} | infectious canine hepatitis {ICH} | charr | emulsin | beta-glucosidase | Subcranial abscess | matrix metalloproteinase {MMP} | syndrome | inflammatory cells | antileukemic drugs | leukemic blasts | cytochemical methods | relapse | measures of diagnostic accuracy | likelihood ratios | area under the ROC curve | Youden\'s index | diagnostic odds ratio {DOR} | predictive ability | brachiocephalic trunk | aortic arch branches | thoracic aorta | neural pathways | body weight support | benign mixed tumor | superficial parotidectomy | parotidectomy | pleomorphic adenoma | Horner`s syndrome | Horner syndrome | Bernard-Horner syndrome | Claude Bernard-Horner syndrome | oculosympathetic palsy | phosphoinositide-3-kinase {PI3K} | cross-sectional analysis | lumbar spine | hospital infections | epidemiological nurse | brachiobicarotid trunk | Hernia of the nucleus pulposus | regional wall motion score index {RWMSI} | S-adenosylmethionine decarboxylase | healthy lifestyle | sports injuries | extensory apparatus | intra-articular fractures | injuries of meniscus | damages of meniscus | knee joint injury | rehabilitation treatment | physiotherapeutist | quadriceps muscle | "get up and go" walking test | walking test | therapeutic rehabilitation | physical education | nursing services | primary health care {PHC} | managing nursing staff | sense of coherence {SOC} | Youden's index | healthcare | health care | thoracentesis | thoracocentesis | pleural tap | bioincompatible | dialysis fluids | uric acid | fructosuria | neutrophile gelatinase aseassociated lipocalin {NGAL} | kidney injury molecule-1 {KIM-1} | early biomarkers | Non-HDL cholesterol {non-HDL-C} | apolipoprotein B100 {apoB} | apolipoprotein AI {apoAI} | apolipoproteins | coughing | radioimmunotherapy | mTOR inhibitors | flavopiridol | chronic phase | malignant hepatoma | ferroportin disease | iron homeostasis | site of administration | real-time polymerase chain reaction {real-time PCR} | drug-metabolizing enzymes | pharmacokinetic-pharmacodynamic modeling {PK/ PD} | pharmacokinetic modeling | thyreotropin | somatotropin | experimental conditions | neuromediators | neuromodulators | habitus | retroviruses-derived sequences | regulatory sequences | retrogene | retroposon | retrotransposon | exogenous retroviruses | endogenous retroviruses | exogenous virus products | human endogenous retroviruses {HERVs} | Keshan disease | cardiovascular system disease {CSD} | antioxidant defense | antioxidant defense of cardiac muscle | midkine | neurite growth-promoting factor 2 {NEGF2} | pleiotrophin | heparin-binding brain mitogen {HBBM} | heparin-binding growth factor 8 {HBGF-8} | neurite growth-promoting factor 1 {NEGF1} | heparin affinity regulatory peptide {HARP} | heparin binding growth associated molecule {HB-GAM} | heparin-binding growth factor | amino-acid sequence | chondroitin sulfate | midkine receptors | multifunctional peptide | gene regulatory sequence | plasticity | sensitivity | heparan sulfate {HS} | anticancer drugs | bisdioxopiperazine | Topoisomerase I inhibitors | analogues of alkaloid camptothecin | camptothecin | cleavable complexes | irinotecan (CPT-11) | demyelination | experimental allergic encephalomyelitis {EAE} | dendritic cells | retroviral vectors | cytogenetic aberrations | translocation t | hyperdiploidy | complex karyotype | cytogenetic profile | hydroxyurea {HU} | hydrolytic enzymes | radicals scavengers | ribonucleotide reductase {RNR} | ribonucleoside diphosphate reductase | unbalanced growth | tyramine | monoamine oxidase inhibitors {MAOIs} | MAO inhibitors | dexrazoxane (ICRF-187) | anthracyclines | ipsilateral | systemic | tyrosine kinase inhibitors | agmatine | arginase | methylarginines | Dimethylarginines | catabolic diseases | auxotrophic | auxotrophic bacteria | auxotrophy | marrow stromal cells | stromal cells | osteoclastogenesis | flexion | pancreatic steatonecrosis |
Poprzednia 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 Nastêpna
